Ailux Biologics, a Division of XtalPi, Enters into a License Agreement with Janssen Biotech on Biologics AI Platform ...Middle East

CAMBRIDGE, Mass., Oct. 10, 2024 /PRNewswire/ -- XtalPi, a global leader in AI drug discovery, announced today a license agreement between Ailux Biologics, a division of XtalPi Inc., and Janssen Biotech, Inc.,(Janssen) a Johnson & Johnson company, on one of its proprietary biologics AI...

Hence then, the article about ailux biologics a division of xtalpi enters into a license agreement with janssen biotech on biologics ai platform was published today ( Thursday 10/10/2024 - 03:52 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Ailux Biologics, a Division of XtalPi, Enters into a License Agreement with Janssen Biotech on Biologics AI Platform )

Also on site :

• Severe Storms Leave More Than 620,000 U.S. Customers Without Power
• Scalefusion Recognized as a High Performer in G2's Europe Regional Grid® for Unified Endpoint Management (UEM)
• Colt DCS appoints David Burton as Chief Information Officer